AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
REVIEW AND EVALUATION OF MRI NONUNIFORMITY CORRECTIONS FOR BRAIN-TUMOR RESPONSE MEASUREMENTS
Authors: VELTHUIZEN RP HEINE JJ CANTOR AB LIN HB FLETCHER LM CLARKE LP
Citation: Rp. Velthuizen et al., REVIEW AND EVALUATION OF MRI NONUNIFORMITY CORRECTIONS FOR BRAIN-TUMOR RESPONSE MEASUREMENTS, Medical physics, 25(9), 1998, pp. 1655-1666
CD44V6 EXPRESSION IN HUMAN COLORECTAL-CARCINOMA
Authors: COPPOLA D HYACINTHE M FU L CANTOR AB KARL R MARCET J COOPER DL NICOSIA SV COOPER HS
Citation: D. Coppola et al., CD44V6 EXPRESSION IN HUMAN COLORECTAL-CARCINOMA, Human pathology, 29(6), 1998, pp. 627-635
BILATERALITY AND RECURRENCE RATES FOR LOBULAR BREAST-CANCER - CONSIDERATIONS FOR TREATMENT
Authors: YEATMAN TJ LYMAN GH SMITH SK REINTGEN DS CANTOR AB COX CE
Citation: Tj. Yeatman et al., BILATERALITY AND RECURRENCE RATES FOR LOBULAR BREAST-CANCER - CONSIDERATIONS FOR TREATMENT, Annals of surgical oncology, 4(3), 1997, pp. 198-202
SAMPLE-SIZE CALCULATIONS FOR COHENS-KAPPA
Authors: CANTOR AB
Citation: Ab. Cantor, SAMPLE-SIZE CALCULATIONS FOR COHENS-KAPPA, Psychological methods, 1(2), 1996, pp. 150-153
POWER CALCULATION FOR THE LOG RANK TEST USING HISTORICAL DATA
Authors: CANTOR AB
Citation: Ab. Cantor, POWER CALCULATION FOR THE LOG RANK TEST USING HISTORICAL DATA, Controlled clinical trials, 17(2), 1996, pp. 111-116
PEPTIDE AMIDATING ACTIVITY IN HUMAN BRONCHOALVEOLAR LAVAGE FLUID
Authors: SCOTT FM TRESTON AM SHAW GL AVIS I SORENSON J KELLY K DEMPSEY EC CANTOR AB TOCKMAN M MULSHINE JL
Citation: Fm. Scott et al., PEPTIDE AMIDATING ACTIVITY IN HUMAN BRONCHOALVEOLAR LAVAGE FLUID, Lung cancer, 14(2-3), 1996, pp. 239-251
MODIFIED HISTOLOGIC GRADING OF NEUROBLASTOMAS BY REPLACEMENT OF MITOTIC RATE WITH MITOSIS KARYORRHEXIS INDEX - A CLINICOPATHOLOGICAL STUDY OF 223 CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP
Authors: JOSHI VV RAO PV CANTOR AB ALTSHULER G SHUSTER JJ CASTLEBERRY RP
Citation: Vv. Joshi et al., MODIFIED HISTOLOGIC GRADING OF NEUROBLASTOMAS BY REPLACEMENT OF MITOTIC RATE WITH MITOSIS KARYORRHEXIS INDEX - A CLINICOPATHOLOGICAL STUDY OF 223 CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP, Cancer, 77(8), 1996, pp. 1582-1588
ALLELIC IMBALANCE ON CHROMOSOME 5Q PREDICTS LONG-TERM SURVIVAL IN NEUROBLASTOMA
Authors: MELTZER SJ ODOHERTY SP FRANTZ CN SMOLINSKI K YIN J CANTOR AB LIU J VALENTINE M BRODEUR GM BERG PE
Citation: Sj. Meltzer et al., ALLELIC IMBALANCE ON CHROMOSOME 5Q PREDICTS LONG-TERM SURVIVAL IN NEUROBLASTOMA, British Journal of Cancer, 74(12), 1996, pp. 1855-1861
CONVENTIONAL VERSUS MODIFIED MORPHOLOGIC CRITERIA FOR GANGLIONEUROBLASTOMA - A REVIEW OF CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP
Authors: JOSHI VV CANTOR AB ALTSHULER G COHEN LJ LARKIN EW SHUSTER JJ RAO PV HOLBROOK CT HAYES FA CASTLEBERRY RP
Citation: Vv. Joshi et al., CONVENTIONAL VERSUS MODIFIED MORPHOLOGIC CRITERIA FOR GANGLIONEUROBLASTOMA - A REVIEW OF CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP, Archives of pathology and laboratory medicine, 120(9), 1996, pp. 859-865
NONRHABDOMYOSARCOMATOUS SOFT-TISSUE SARCOMAS OF CHILDHOOD - FORMULATION OF A SIMPLIFIED SYSTEM FOR GRADING
Authors: PARHAM DM WEBBER BL JENKINS JJ CANTOR AB MAURER HM
Citation: Dm. Parham et al., NONRHABDOMYOSARCOMATOUS SOFT-TISSUE SARCOMAS OF CHILDHOOD - FORMULATION OF A SIMPLIFIED SYSTEM FOR GRADING, Modern pathology, 8(7), 1995, pp. 705-710
A TEST OF THE ASSOCIATION OF A TIME-DEPENDENT STATE-VARIABLE TO SURVIVAL
Authors: CANTOR AB
Citation: Ab. Cantor, A TEST OF THE ASSOCIATION OF A TIME-DEPENDENT STATE-VARIABLE TO SURVIVAL, Computer methods and programs in biomedicine, 46(2), 1995, pp. 101-105
TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE INPEDIATRIC-PATIENTS WITH RECURRENT DISEASE VERSUS PATIENTS PREVIOUSLY UNTREATED - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: HARRIS MB CANTOR AB GOORIN AM SHOCHAT SJ AYALA AG FERGUSON WS HOLBROOK T LINK MP
Citation: Mb. Harris et al., TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE INPEDIATRIC-PATIENTS WITH RECURRENT DISEASE VERSUS PATIENTS PREVIOUSLY UNTREATED - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Medical and pediatric oncology, 24(2), 1995, pp. 87-92
BIOLOGICAL VARIABLES IN THORACIC NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: MORRIS JA SHOCHAT SJ SMITH EI LOOK AT BRODEUR GM CANTOR AB CASTLEBERRY RP
Citation: Ja. Morris et al., BIOLOGICAL VARIABLES IN THORACIC NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of pediatric surgery, 30(2), 1995, pp. 296-303
AGE AND FAMILY RELATIONSHIP ACCENTUATE THE RISK OF INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) IN RELATIVES OF PATIENTS WITH IDDM
Authors: CANTOR AB KRISCHER JP CUTHBERTSON DD SCHATZ DA RILEY WJ MALONE J SCHWARTZ S QUATTRIN T MACLAREN NK
Citation: Ab. Cantor et al., AGE AND FAMILY RELATIONSHIP ACCENTUATE THE RISK OF INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) IN RELATIVES OF PATIENTS WITH IDDM, The Journal of clinical endocrinology and metabolism, 80(12), 1995, pp. 3739-3743
TUMOR BIOLOGY OF INFILTRATING LOBULAR CARCINOMA - IMPLICATIONS FOR MANAGEMENT
Authors: YEATMAN TJ CANTOR AB SMITH TJ SMITH SK REINTGEN DS MILLER MS KU NNK BAEKEY PA COX CE
Citation: Tj. Yeatman et al., TUMOR BIOLOGY OF INFILTRATING LOBULAR CARCINOMA - IMPLICATIONS FOR MANAGEMENT, Annals of surgery, 222(4), 1995, pp. 549-561
RE - DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS
Authors: CANTOR AB SHUSTER JJ
Citation: Ab. Cantor et Jj. Shuster, RE - DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS, Journal of the National Cancer Institute, 86(23), 1994, pp. 1798-1799
PHASE-II INVESTIGATIONAL WINDOW USING CARBOPLATIN, IPROPLATIN, IFOSFAMIDE, AND EPIRUBICIN IN CHILDREN WITH UNTREATED DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: CASTLEBERRY RP CANTOR AB GREEN AA JOSHI V BERKOW RL BUCHANAN GR LEVENTHAL B MAHONEY DH SMITH EI HAYES FA
Citation: Rp. Castleberry et al., PHASE-II INVESTIGATIONAL WINDOW USING CARBOPLATIN, IPROPLATIN, IFOSFAMIDE, AND EPIRUBICIN IN CHILDREN WITH UNTREATED DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(8), 1994, pp. 1616-1620
PARAMETRIC VERSUS NONPARAMETRIC METHODS FOR ESTIMATING CURE RATES BASED ON CENSORED SURVIVAL-DATA - REPLY
Authors: CANTOR AB SHUSTER JJ
Citation: Ab. Cantor et Jj. Shuster, PARAMETRIC VERSUS NONPARAMETRIC METHODS FOR ESTIMATING CURE RATES BASED ON CENSORED SURVIVAL-DATA - REPLY, Statistics in medicine, 13(9), 1994, pp. 986-986
THE ROLE OF PROGNOSTIC FACTORS IN TREATMENT SELECTION FOR EARLY-STAGEHODGKINS-DISEASE
Authors: MENDENHALL NP CANTOR AB BARRE DM LYNCH JW MILLION RR
Citation: Np. Mendenhall et al., THE ROLE OF PROGNOSTIC FACTORS IN TREATMENT SELECTION FOR EARLY-STAGEHODGKINS-DISEASE, American journal of clinical oncology, 17(3), 1994, pp. 189-195
WITH MODERN IMAGING TECHNIQUES, IS STAGING LAPAROTOMY NECESSARY IN PEDIATRIC HODGKINS-DISEASE - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: MENDENHALL NP CANTOR AB WILLIAMS JL TERNBERG JL WEINER MA KUNG FH MARCUS RB FERREE CR LEVENTHAL BG
Citation: Np. Mendenhall et al., WITH MODERN IMAGING TECHNIQUES, IS STAGING LAPAROTOMY NECESSARY IN PEDIATRIC HODGKINS-DISEASE - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 11(11), 1993, pp. 2218-2225
SYSTEMATIZATION OF PRIMARY HISTOPATHOLOGIC AND FINE-NEEDLE ASPIRATIONCYTOLOGIC FEATURES AND DESCRIPTION OF UNUSUAL HISTOPATHOLOGIC FEATURES OF NEUROBLASTIC TUMORS - A REPORT FROM THE PEDIATRIC ONCOLOGY GROUP
Authors: JOSHI VV SILVERMAN JF ALTSHULER G CANTOR AB LARKIN EW NEILL JSA NORRIS HT SHUSTER JJ HOLBROOK CT HAYES FA SMITH EI CASTLEBERRY RP
Citation: Vv. Joshi et al., SYSTEMATIZATION OF PRIMARY HISTOPATHOLOGIC AND FINE-NEEDLE ASPIRATIONCYTOLOGIC FEATURES AND DESCRIPTION OF UNUSUAL HISTOPATHOLOGIC FEATURES OF NEUROBLASTIC TUMORS - A REPORT FROM THE PEDIATRIC ONCOLOGY GROUP, Human pathology, 24(5), 1993, pp. 493-504
CORRELATION BETWEEN MORPHOLOGIC AND OTHER PROGNOSTIC MARKERS OF NEUROBLASTOMA - A STUDY OF HISTOLOGIC GRADE, DNA INDEX, N-MYC GENE COPY NUMBER, AND LACTIC-DEHYDROGENASE IN PATIENTS IN THE PEDIATRIC ONCOLOGY GROUP
Authors: JOSHI VV CANTOR AB BRODEUR GM LOOK AT SHUSTER JJ ALTSHULER G LARKIN EW HOLBROOK CT SILVERMAN JF NORRIS HT HAYES FA SMITH EI CASTLEBERRY RP
Citation: Vv. Joshi et al., CORRELATION BETWEEN MORPHOLOGIC AND OTHER PROGNOSTIC MARKERS OF NEUROBLASTOMA - A STUDY OF HISTOLOGIC GRADE, DNA INDEX, N-MYC GENE COPY NUMBER, AND LACTIC-DEHYDROGENASE IN PATIENTS IN THE PEDIATRIC ONCOLOGY GROUP, Cancer, 71(10), 1993, pp. 3173-3181
A NOTE ON THE KAPLAN-MEIER ESTIMATOR - COMMENT
Authors: SHUSTER JJ CANTOR AB
Citation: Jj. Shuster et Ab. Cantor, A NOTE ON THE KAPLAN-MEIER ESTIMATOR - COMMENT, The American statistician, 47(4), 1993, pp. 313-313
LOSS OF HETEROZYGOSITY FOR CHROMOSOME-1 OR CHROMOSOME-14 DEFINES SUBSETS OF ADVANCED NEUROBLASTOMAS
Authors: FONG CT WHITE PS PETERSON K SAPIENZA C CAVENEE WK KERN SE VOGELSTEIN B CANTOR AB LOOK AT BRODEUR GM
Citation: Ct. Fong et al., LOSS OF HETEROZYGOSITY FOR CHROMOSOME-1 OR CHROMOSOME-14 DEFINES SUBSETS OF ADVANCED NEUROBLASTOMAS, Cancer research, 52(7), 1992, pp. 1780-1785
RECOMMENDATIONS FOR MODIFICATION OF TERMINOLOGY OF NEUROBLASTIC TUMORS AND PROGNOSTIC-SIGNIFICANCE OF SHIMADA CLASSIFICATION - A CLINICOPATHOLOGICAL STUDY OF 213 CASES FROM THE PEDIATRIC ONCOLOGY GROUP
Authors: JOSHI VV CANTOR AB ALTSHULER G LARKIN EW NEILL JSA SHUSTER JJ HOLBROOK CT HAYES FA CASTLEBERRY RP
Citation: Vv. Joshi et al., RECOMMENDATIONS FOR MODIFICATION OF TERMINOLOGY OF NEUROBLASTIC TUMORS AND PROGNOSTIC-SIGNIFICANCE OF SHIMADA CLASSIFICATION - A CLINICOPATHOLOGICAL STUDY OF 213 CASES FROM THE PEDIATRIC ONCOLOGY GROUP, Cancer, 69(8), 1992, pp. 2183-2196
Risultati: 1-25 | 26-26